A patent perspective of RSK inhibitors to treat cancers (2020 - present)
{{output}}
Introduction: The Ser/Thr protein kinase family, p90ribosomal S6 kinase (RSK), can be activated by inputs from ERK1/2, PDK1 and in some cases MK1/MK2. Dysregulated RSK activity is implicated in diseases associated with inflammati... ...
